Save your place

Sign in to WhoBought

Please try again later.

Humacyte, Inc. (HUMA) institutional ownership

Latest close $0.67 Jul 21, 2026
Market cap$334M 52-week range SectorHealthcare
Funds holding · Q1 2026
131
reported HUMA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
83 buyers · 48 sellers

Humacyte, Inc. (HUMA) price and institutional activity

Dates

Q1 2026

$0 bought by 83 investors
Antipodes Partners LtdGreat Point Partners LLC +81 more
$0 sold by 48 investors
Millennium Management LLCMorgan Stanley +46 more
Bought Sold Totals per quarter; hover a bar for the names.

Humacyte, Inc. (HUMA) institutional activity · 83

Investor Type Est. change Change Δ Own Date
Antipodes Partners Ltd · Added
Change +5.7M Date Q1 2026
Antipodes Partners Ltd Added· Q1 2026 +5.7M Q1 2026
Great Point Partners LLC · New
Change +3.8M Date Q1 2026
Great Point Partners LLC New· Q1 2026 +3.8M Q1 2026
AQR Capital Management LLC · Added
Change +1.9M Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +1.9M Q1 2026
Vanguard · Added
Change +1.2M Date Q1 2026
Vanguard Added· Q1 2026 +1.2M Q1 2026
BlackRock · Added
Change +972K Date Q1 2026
BlackRock Added· Q1 2026 +972K Q1 2026
Private Advisor Group, LLC · Added
Change +271K Date Q1 2026
Private Advisor Group, LLC Added· Q1 2026 +271K Q1 2026
Ieq Capital, LLC · New
Change +264K Date Q1 2026
Ieq Capital, LLC New· Q1 2026 +264K Q1 2026
Gsa Capital Partners LLP · New
Change +250K Date Q1 2026
Gsa Capital Partners LLP New· Q1 2026 +250K Q1 2026
Goldman Sachs Group Inc · Added
Change +250K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +250K Q1 2026
State Street · Added
Change +207K Date Q1 2026
State Street Added· Q1 2026 +207K Q1 2026
Lion Point Capital, LP · Added
Change +150K Date Q1 2026
Lion Point Capital, LP Added· Q1 2026 +150K Q1 2026
Invesco Ltd. · Added
Change +134K Δ Own +344.1% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +134K +344.1% Q1 2026
Mariner, LLC · New
Change +106K Date Q1 2026
Mariner, LLC New· Q1 2026 +106K Q1 2026
Cwm, LLC · Added
Change +97K Date Q1 2026
Cwm, LLC Added· Q1 2026 +97K Q1 2026
Nuveen, LLC · Added
Change +88K Date Q1 2026
Nuveen, LLC Added· Q1 2026 +88K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 83

Famous investor activity in Humacyte, Inc. (HUMA)

Humacyte, Inc. (HUMA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Windham-Bannister Susan Richards · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Windham-Bannister Susan Richards Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Constantino Michael T. · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Constantino Michael T. Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Wallace Max N. · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Wallace Max N. Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Niklason Laura E. · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Niklason Laura E. Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Sebelius Kathleen · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Sebelius Kathleen Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Jones Keith Anthony · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Jones Keith Anthony Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Green Charles Bruce · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Green Charles Bruce Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Seimetz Diane · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Seimetz Diane Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Bamforth John Philip · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Bamforth John Philip Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Brown Emery N. · Director Grant (A) 80K
Owned 80K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Brown Emery N. Director Grant (A) 80K 80K Jun 11, 2026 Jun 12, 2026
Dougan Brady W. · Director Grant (A) 80K
Owned 0 Trade date Jun 11, 2026 Filed date Jun 12, 2026
Dougan Brady W. Director Grant (A) 80K 0 Jun 11, 2026 Jun 12, 2026
Sebelius Kathleen · Director Buy +$50K
Price $0.88 Qty +57K Owned 148K Trade date May 19, 2026 Filed date May 20, 2026
Sebelius Kathleen Director Buy $0.88 +57K +$50K 148K May 19, 2026 May 20, 2026
Constantino Michael T. · Director Buy +$10K
Price $0.89 Qty +11K Owned 44K Trade date May 18, 2026 Filed date May 20, 2026
Constantino Michael T. Director Buy $0.89 +11K +$10K 44K May 18, 2026 May 20, 2026
Sander Dale A. · Officer Sell −$41K
Price $0.90 Qty −46K Owned 267K Trade date May 18, 2026 Filed date May 20, 2026
Sander Dale A. Officer Sell $0.90 −46K −$41K 267K May 18, 2026 May 20, 2026
Parikh Shamik J. · Officer Sell −$41K
Price $0.90 Qty −46K Owned 273K Trade date May 18, 2026 Filed date May 20, 2026
Parikh Shamik J. Officer Sell $0.90 −46K −$41K 273K May 18, 2026 May 20, 2026
15 of 25
15 of 25 Sign in to continue to older insider transactions.

Humacyte, Inc. (HUMA) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Fresenius Medical Care Holdings Inc 18.3M
% of shares outstanding 14.2% Filing date Nov 18, 2024
Fresenius Medical Care Holdings Inc 18.3M 14.2% Nov 18, 2024
Ptc Trustees Gy Ltd AS Trustee of the Gyf Trust 8.9M
% of shares outstanding 8.7% Filing date Sep 8, 2021
Ptc Trustees Gy Ltd AS Trustee of the Gyf Trust 8.9M 8.7% Sep 8, 2021
Blackrock, Inc. 7.5M
% of shares outstanding 6.3% Filing date Nov 8, 2024
Blackrock, Inc. 7.5M 6.3% Nov 8, 2024
Niklason Laura E 6.0M
% of shares outstanding 4.6% Filing date Nov 20, 2024
Niklason Laura E 6.0M 4.6% Nov 20, 2024
M.h. Davidson & Co. 233K
% of shares outstanding 0.1% Filing date Jun 22, 2026
M.h. Davidson & Co. 233K 0.1% Jun 22, 2026
Glazer Capital, LLC
% of shares outstanding 0.0% Filing date Feb 14, 2022
Glazer Capital, LLC 0.0% Feb 14, 2022
Parian Global Management LP
% of shares outstanding 0.0% Filing date Feb 9, 2022
Parian Global Management LP 0.0% Feb 9, 2022
7 of 7

Humacyte, Inc. (HUMA) ownership FAQ

Who owns HUMA?

131 reporting institutions disclosed HUMA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.